North America Lymphedema Treatment Market is expected to grow with a CAGR of 9.7% in the forecast period of 2022 to 2029. The years considered for the study are as mentioned below:
Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-lymphedema-treatment-market
North America lymphedema treatment market is a highly consolidated market. The market has witnessed increased strategic developments owing to a favorable market scenario.
The major players dealing in the North America lymphedema treatment market are introducing a strong range of product portfolios. This helped companies to maximize sales with an enhanced product portfolio.
Tactile Medical is the dominating player in the market. Some of the other major manufacturers for the North America lymphedema treatment market are BIOCOMPRESSION SYSTEMS, Lohmann & Rauscher GmbH & Co. KG, ThermoTek, Essity (BSN medical GmbH), Cardinal Health, Smith+Nephew, Avet Pharmaceuticals Inc., KOYA MEDICAL, SIGVARIS GROUP, AIROS Medical, Inc., Tactile Medical, medi GmbH & Co. KG, PAUL HARTMANN AG, Convatec Inc., 3M, JUZO, Mego Afek ltd, Huntleigh Healthcare Limited, HERANTIS PHARMA Plc, among others.
Tactile Medical
Tactile Medical was founded in 1957 and is headquartered in Minnesota, United States. It has public ownership. The company focuses on developing and marketing at-home therapy devices that treat lymphedema and chronic venous insufficiency. The company offers a range of product categories, including head and neck, upper body, lower body which are also the market-focused categories.
The company has a global presence in North America. The company has a subsidiary, Swelling Solutions, Inc. (U.S.).
Essity (BSN medical GmbH)
Essity (BSN medical GmbH) was founded in 1950 and is headquartered in Hamburg, Germany. It has private ownership. The company focuses on improving well-being through leading hygiene and health solutions. The company offers a range of product categories, including phlebology, lymphology, chronic venous disease, lymphedema, chronic venous insufficiency, thrombosis prophylaxis, and chronic edema, out of which lymphedema is the market-focused category. The company is taking strategic initiatives to increase its portfolio.
The company has a global presence in Europe.
3M
3M was founded in 1902 and is headquartered in Minnesota, U.S. It has public ownership. The company's main focus is on advanced wound care and specialty surgical applications. The company's business segments include safety and industrial, transportation and electronics, health care, consumer, out of which health care is the market-focused segment. The company offers various product categories such as abrasive, sealant, filler, building material, cleaning supplies, coatings, insulation, lab supplies and testing, labels, lubricants, medical tapes, bandages, and wraps, out of which the market-focused categories are bandages and wraps. The company is taking strategic initiatives to increase its portfolio.
The company has a global presence in North America, Europe, the Middle East and Africa, Asia-Pacific, and South America. Some of the subsidiaries of the company include 3M Membrane Filtration (formerly Membrana) (Germany), 3M Food Safety (United Kingdom), 3M Purification Inc. (Connecticut), and 3M Personal Safety Division (Minnesota), among others.
Global Lymphedema Treatment Market – Industry Trends and Forecast to 2029
Europe Lymphedema Treatment Market – Industry Trends and Forecast to 2029
Middle East and Africa Lymphedema Treatment Market – Industry Trends and Forecast to 2029
Asia-Pacific Lymphedema Treatment Market – Industry Trends and Forecast to 2029
North America Lymphedema Treatment Market – Industry Trends and Forecast to 2029